2019
DOI: 10.1016/j.canlet.2019.04.006
|View full text |Cite
|
Sign up to set email alerts
|

miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
50
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 65 publications
(54 citation statements)
references
References 41 publications
4
50
0
Order By: Relevance
“…11 In triple-negative breast cancer, ARRB1 was a direct target of miR-374a, and knockdown of miR-374a attenuated cell proliferation and migration in vitro. 13 Long-rank test, p = .032…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…11 In triple-negative breast cancer, ARRB1 was a direct target of miR-374a, and knockdown of miR-374a attenuated cell proliferation and migration in vitro. 13 Long-rank test, p = .032…”
Section: Discussionmentioning
confidence: 99%
“…Low miR-374a regulation of miR-374a inhibited tumor growth and decreased Ki-67 proliferation index in xenograft mice. 13 However, some studies have reported miR-374a as a tumor suppressive miRNA. Induced overexpression of miR-374a in colon cancer cell lines inhibited cell proliferation and invasion based on in vitro assays and a xenograft model by targeting cyclin D1.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…On the other hand, oncogenic miRNAs also play crucial roles in TNBC. MiR‐498, miR‐374a‐5p and miR‐761 were significantly overexpressed in TNBC and promoted cell proliferation and migration by downregulating PTEN, ARRB1 and TRIM29, respectively 37‐39 . Moreover, the miR‐106b‐25 cluster mediated oncogenesis in breast cancer by activation of NOTCH1 by targeting NEDD4L in both ER+ and TNBC breast cancer cells, suggesting that the miR‐106b‐25/NEDD4L/NOTCH1 axis played a crucial role in breast cancer 40 .…”
Section: Micrornasmentioning
confidence: 99%
“…About 20% of BCs in China are TNBC subtype (Peng et al, 2016). TNBC is the most aggressive subtype of BC and is associated with worst prognosis and overall survival (OS; Son et al, 2019). It is characterized by high cell proliferation, poor cellular differentiation, and more frequent disease recurrence (Chang et al, 2018).…”
Section: Introductionmentioning
confidence: 99%